GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgery Partners Inc (NAS:SGRY) » Definitions » Cyclically Adjusted Price-to-FCF

Surgery Partners (Surgery Partners) Cyclically Adjusted Price-to-FCF : 13.03 (As of Jun. 06, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Surgery Partners Cyclically Adjusted Price-to-FCF?

As of today (2024-06-06), Surgery Partners's current share price is $25.93. Surgery Partners's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $1.99. Surgery Partners's Cyclically Adjusted Price-to-FCF for today is 13.03.

The historical rank and industry rank for Surgery Partners's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SGRY' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 11.1   Med: 14.5   Max: 17.12
Current: 13.27

During the past years, Surgery Partners's highest Cyclically Adjusted Price-to-FCF was 17.12. The lowest was 11.10. And the median was 14.50.

SGRY's Cyclically Adjusted Price-to-FCF is ranked better than
71.02% of 176 companies
in the Healthcare Providers & Services industry
Industry Median: 23.74 vs SGRY: 13.27

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Surgery Partners's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $0.156. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $1.99 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Surgery Partners Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Surgery Partners's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgery Partners Cyclically Adjusted Price-to-FCF Chart

Surgery Partners Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 16.03

Surgery Partners Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 14.47 16.03 14.98

Competitive Comparison of Surgery Partners's Cyclically Adjusted Price-to-FCF

For the Medical Care Facilities subindustry, Surgery Partners's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgery Partners's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Surgery Partners's Cyclically Adjusted Price-to-FCF falls into.



Surgery Partners Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Surgery Partners's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=25.93/1.99
=13.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgery Partners's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Surgery Partners's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.156/131.7762*131.7762
=0.156

Current CPI (Mar. 2024) = 131.7762.

Surgery Partners Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.084 99.621 0.111
201506 0.320 100.684 0.419
201509 0.472 100.392 0.620
201512 0.184 99.792 0.243
201603 0.280 100.470 0.367
201606 0.836 101.688 1.083
201609 0.225 101.861 0.291
201612 0.444 101.863 0.574
201703 0.594 102.862 0.761
201706 0.267 103.349 0.340
201709 0.000 104.136 0.000
201712 0.000 104.011 0.000
201803 0.417 105.290 0.522
201806 0.702 106.317 0.870
201809 0.391 106.507 0.484
201812 0.672 105.998 0.835
201903 0.181 107.251 0.222
201906 0.139 108.070 0.169
201909 0.797 108.329 0.970
201912 0.041 108.420 0.050
202003 0.359 108.902 0.434
202006 3.559 108.767 4.312
202009 0.389 109.815 0.467
202012 -0.127 109.897 -0.152
202103 0.652 111.754 0.769
202106 -0.162 114.631 -0.186
202109 -0.007 115.734 -0.008
202112 0.066 117.630 0.074
202203 0.682 121.301 0.741
202206 0.222 125.017 0.234
202209 0.139 125.227 0.146
202212 -0.152 125.222 -0.160
202303 0.401 127.348 0.415
202306 0.206 128.729 0.211
202309 0.682 129.860 0.692
202312 0.340 129.419 0.346
202403 0.156 131.776 0.156

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Surgery Partners  (NAS:SGRY) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Surgery Partners Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Surgery Partners's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgery Partners (Surgery Partners) Business Description

Traded in Other Exchanges
N/A
Address
340 Seven Springs Way, Suite 600, Brentwood, TN, USA, 37027
Surgery Partners Inc is one of the few remaining independent ambulatory surgery center operators in the U.S. with national scale. The firm operates surgical facilities in approximately 30 states in partnership with physician groups and larger local healthcare systems. While surgical procedures drive a majority of the firm's revenue, the company also operates a clinical lab, urgent care facilities, and a handful of physician practices to provide additional healthcare services within the communities it serves. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.
Executives
Bain Capital Investors Llc director, 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116
Wayne S Deveydt director, officer: Chief Executive Officer 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
T. Devin O'reilly director, 10 percent owner C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02149
Blair E Hendrix director, 10 percent owner
Andrew T. Kaplan director C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Jason Eric Evans officer: EVP & Chief Operating Officer 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Harrison R. Bane officer: American Group President 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
David T Doherty officer: Chief Financial Officer 310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Bradley R. Owens officer: National Group President 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Danielle Burkhalter officer: Chief Human Resources Officer 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Anthony Taparo officer: President, Atlantic Group 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Jennifer Baldock officer: Sr. VP, Gen Couns. & Sec. 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Marissa Brittenham officer: Chief Strategy Officer 310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Bain Capital Fund Xi, L.p. director, 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Partners Xi, L.p. director, 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116